Report on Repeated Mifepristone Treatment for Uterine Fibroids or Endometriosis

Josep Lluís Carbonell Esteve, Rita Acosta, Yasmirian Pérez, Riveron Ana Maria, Gonzalez Jesus, Carlos Sanchez, Giuseppe Tomasi
In: Journal of Clinical Gynecology and Obstetrics · 2013 · vol. 2(1) , pp. 31–37 · doi:10.4021/jcgo.v2i1.171 · W2076767069
OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This study found that repeated low-dose mifepristone treatments for uterine fibroids or endometriosis, with variable rest intervals, did not appear to pose health risks to women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background: No information is available on how repeated administration of mifepristone could affect women ’ s health. Methods: A total of 101 and 36 subjects who participated in up to 2 and 3 mifepristone trials to treat endometriosis or uterine fibroids, respectively, carried out at the “ Eusebio Hernandez ” Hospital, Havana, Cuba. Results: Subjects who repeated mifepristone to treat fibroids did so for 7.3 ± 2.5 months, minimum and maximum of 6 and 15 months, respectively. The average rest interval was 9.7 ± 6.2 months, minimum and maximum of 3 and 30 months, respectively. In subjects repeating mifepristone for endometriosis, the average was 18 ± 2.0, with a minimum and maximum of 12 and 24 months, respectively. The average rest interval was 8.3 ± 5.3 months, 95% CI = 7.6 - 8.9, minimum and maximum of 3 and 30 months, respectively. No change in women ’ s health was detected months after termination of final mifepristone treatment. Conclusions: Repeating low doses mifepristone treatment up to 3 - 4 times for 3, 6 or 9 months duration with variable rest intervals between sessions, did not seem to involve any risk to health. More studies to confirm the long-term safety of repeated low dosage mifepristone are mandatory. doi: http://dx.doi.org/10.4021/jcgo148e

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (19)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK